Preliminary data from an artificial intelligence (AI) model could potentially predict side effects resulting from new combination drug therapies, according to results presented at the American Association for Cancer Research (AACR) Annual Meeting, held April 8-13 in New Orleans. This presentation, and other meeting presentations/sessions, can be viewed on the virtual platform by registered meeting participants through July 13, 2022. Registration can be done here. Over 19,000 scientists and physicians registered for this premier cancer conference, with ~80% (~15,200) attending in person and ~20% (~3,800) attending virtually. The AACR has over 50,000 members worldwide.
Login Or Register To Read Full Story